Progress of manganese-based nanomaterials in breast cancer diagnosis and treatment

Abstract

Tao Jin, Kan Junnan, Yang Caixia, Liu Yan, Lyu Yijie, Wei Junhui, Li Xianglin. Progress of manganese-based nanomaterials in breast cancer diagnosis and treatment[J]. Journal of International Oncology, 2024, 51(10): 645-649.

References37

[1]	赵倩雯, 彭丹莉, 秦韬, 等. 1990—2019年全球肿瘤发病死亡分析[J].国际肿瘤学杂志,2023,50(7): 425-431. DOI:10.3760/cma.j.cn371439-20230315-00082.
[2]	Sun Z, Wang Z, Wang T, et al. Biodegradable MnO-based nanoparticles with engineering surface for tumor therapy: simultaneous fenton-like ion delivery and immune activation[J].ACS Nano,2022,16(8): 11862-11875. DOI:10.1021/acsnano.2c00969. pmid:35925671
[3]	Jain P, Jangid AK, Pooja D, et al. Designing of manganese-based nanomaterials for pharmaceutical and biomedical applications[J].J Mater Chem B,2024,12(3): 577-608. DOI:10.1039/d3tb00779k.
[4]	Wekking D, Porcu M, De Silva P, et al. Breast MRI: clinical indications, recommendations, and future applications in breast cancer diagnosis[J].Curr Oncol Rep,2023,25(4): 257-267. DOI:10.1007/s11912-023-01372-x. pmid:36749493
[5]	Chen X, Teng S, Li J, et al. Gadolinium(Ⅲ)-chelated deformable mesoporous organosilica nanoparticles as magnetic resonance imaging contrast agent[J].Adv Mater,2023,35(20): 2211578. DOI:10.1002/adma.202211578.
[6]	Daksh S, Kaul A, Deep S, et al. Current advancement in the development of manganese complexes as magnetic resonance imaging probes[J].J Inorg Biochem,2022,237: 112018. DOI:10.1016/j.jinorgbio.2022.112018.
[7]	Ouyang S, Chen C, Lin P, et al. Hydrogen-bonded organic frameworks chelated manganese for precise magnetic resonance imaging diagnosis of cancers[J].Nano Lett,2023,23(18): 8628-8636. DOI:10.1021/acs.nanolett.3c02466. pmid:37694968
[8]	Carniato F, Ricci M, Tei L, et al. Novel nanogels loaded with Mn(Ⅱ)chelates as effective and biologically stable MRI probes[J].Small,2023,19(42): 2302868. DOI:10.1002/smll.202302868.
[9]	Liu Y, Bhattarai P, Dai Z, et al. Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer[J].Chem Soc Rev,2019,48(7): 2053-2108. DOI:10.1039/c8cs00618k. pmid:30259015
[10]	Yu Y, Feng T, Qiu H, et al. Simultaneous photoacoustic and ultrasound imaging: a review[J].Ultrasonics,2024,139: 107277. DOI:10.1016/j.ultras.2024.107277.
[11]	Neuschler EI, Butler R, Young CA, et al. A pivotal study of optoacoustic imaging to diagnose benign and malignant breast masses: a new evaluation tool for radiologists[J].Radiology,2018,287(2): 398-412. DOI:10.1148/radiol.2017172228. pmid:29178816
[12]	Teng L, Han X, Liu Y, et al. Smart nanozyme platform with activity-correlated ratiometric molecular imaging for predicting therapeutic effects[J].Angew Chem Int Ed Engl,2021,133(50): 26346-26354. DOI:10.1002/anie.202110427.
[13]	Tang Q, Cheng Z, Yang N, et al. Hydrangea-structured tumor microenvironment responsive degradable nanoplatform for hypoxic tumor multimodal imaging and therapy[J].Biomaterials,2019,205: 1-10. DOI:10.1016/j.biomaterials.2019.03.005. pmid:30889497
[14]	Lv Y, Kan J, Luo M, et al. Multifunctional nanosnowflakes for T1-T2 double-contrast enhanced MRI and PAI guided oxygen self-supplementing effective anti-tumor therapy[J].Int J Nanomedicine,2022,17: 4619-4638. DOI:10.2147/IJN.S379526.
[15]	Vogel A, Meyer T, Sapisochin G, et al. Hepatocellular carcinoma[J].Lancet,2022,400(10360): 1345-1362. DOI:10.1016/S0140-6736(22)01200-4. pmid:36084663
[16]	Weber WA, Barthel H, Bengel F, et al. What is theranostics?[J].J Nucl Med,2023,64(5): 669-670. DOI:10.2967/jnumed.123.265670.
[17]	Pan YB, Xu CX, Deng HZ, et al. Localized NIR-Ⅱ laser mediated chemodynamic therapy of glioblastoma[J].Nano Today,2022,43: 101435. DOI:10.1016/j.nantod.2022.101435.
[18]	Zhang L, Yang Z, He W, et al. One-pot synthesis of a self-reinforcing cascade bioreactor for combined photodynamic/chemodynamic/starvation therapy[J].J Colloid Interface Sci,2021,599: 543-555. DOI:10.1016/j.jcis.2021.03.173.
[19]	Xu X, Zhang R, Yang X, et al. A honeycomb-like bismuth/manganese oxide nanoparticle with mutual reinforcement of internal and external response for triple-negative breast cancer targeted therapy[J].Adv Healthc Mater,2021,10(18): 2100518. DOI:10.1002/adhm.202100518.
[20]	Adams S, Gatti-Mays ME, Kalinsky K, et al. Current landscape of immunotherapy in breast cancer: a review[J].JAMA Oncol,2019,5(8): 1205-1214. DOI:10.1001/jamaoncol.2018.7147.
[21]	Lv MZ, Chen MX, Zhang R, et al. Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy[J].Cell Res,2020,30(11): 966-979. DOI:10.1038/s41422-020-00395-4.
[22]	Zhong H, Chen G, Li T, et al. Nanodrug augmenting antitumor immunity for enhanced TNBC therapy via pyroptosis and cGAS-STING activation[J].Nano Lett,2023,23(11): 5083-5091. DOI:10.1021/acs.nanolett.3c01008.
[23]	Rashid NS, Grible JM, Clevenger CV, et al. Breast cancer liver metastasis: current and future treatment approaches[J].Clin Exp Metastasis,2021,38(3): 263-277. DOI:10.1007/s10585-021-10080-4.
[24]	Zhong Y, Li T, Zhu Y, et al. Targeting proinflammatory molecules using multifunctional MnO nanoparticles to inhibit breast cancer recurrence and metastasis[J].ACS Nano,2022,16(12): 20430-20444. DOI:10.1021/acsnano.2c06713. pmid:36382718
[25]	Wang SB, Zhang C, Ye JJ, et al. Near-infrared light responsive nanoreactor for simultaneous tumor photothermal therapy and carbon monoxide-mediated anti-inflammation[J].ACS Cent Sci,2020,6(4): 555-565. DOI:10.1021/acscentsci.9b01342.
[26]	Peng J, Dong M, Ran B, et al. "One-for-All"-type, biodegradable prussian blue/manganese dioxide hybrid nanocrystal for trimodal imaging-guided photothermal therapy and oxygen regulation of breast cancer[J].ACS Appl Mater Interfaces,2017,9(16): 13875-13886. DOI:10.1021/acsami.7b01365.
[27]	Xie W, Guo Z, Gao Q, et al. Manganese-doped layered double hydroxide: a biodegradable theranostic nanoplatform with tumor microenvironment response for magnetic resonance imaging-guided photothermal therapy[J].ACS Appl Bio Mater,2020,3(9): 5845-5855. DOI:10.1021/acsabm.0c00564. pmid:35021812
[28]	Niu B, Liao K, Zhou Y, et al. Application of glutathione depletion in cancer therapy: enhanced ROS-based therapy, ferroptosis, and chemotherapy[J].Biomaterials,2021,277: 121110. DOI:10.1016/j.biomaterials.2021.121110.
[29]	Yuan P, Deng FA, Liu YB, et al. Mitochondria targeted O₂economizer to alleviate tumor hypoxia for enhanced photodynamic therapy[J].Adv Healthc Mater,2021,10(12): 2100198. DOI:10.1002/adhm.202100198.
[30]	Zhou X, Xu X, Hu Q, et al. Novel manganese and polyester dendrimer-based theranostic nanoparticles for MRI and breast cancer therapy[J].J Mater Chem B,2023,11(3): 648-656. DOI:10.1039/d2tb01855a.
[31]	Li W, Li R, Ye Q, et al. Mn₃O₄nanoshell coated metal-organic frameworks with microenvironment-driven O₂production and GSH exhaustion ability for enhanced chemodynamic and photodynamic cancer therapies[J].Adv Healthc Mater,2023,12(15): 2202280. DOI:10.1002/adhm.202202280.
[32]	Beckers C, Pruschy M, Vetrugno I. Tumor hypoxia and radiotherapy: a major driver of resistance even for novel radiotherapy modalities[J].Semin Cancer Biol,2024,98: 19-30. DOI:10.1016/j.semcancer.2023.11.006. pmid:38040401
[33]	He Z, Yan H, Zeng W, et al. Tumor microenvironment-responsive multifunctional nanoplatform based on MnFe₂O₄-PEG for enhanced magnetic resonance imaging-guided hypoxic cancer radiotherapy[J].J Mater Chem B,2021,9(6): 1625-1637. DOI:10.1039/d0tb02631j.
[34]	Hu H, Zheng S, He C, et al. Radiotherapy-sensitized cancer immunotherapy via cGAS-STING immune pathway by activatable nanocascade reaction[J].J Nanobiotechnology,2024,22(1): 234. DOI:10.1186/s12951-024-02502-8.
[35]	Xiong Y, Xiao C, Li Z, et al. Engineering nanomedicine for glutathione depletion-augmented cancer therapy[J].Chem Soc Rev,2021,50(10): 6013-6041. DOI:10.1039/d0cs00718h. pmid:34027953
[36]	Zhang H, Li M, Zhu X, et al. Artemisinin co-delivery system based on manganese oxide for precise diagnosis and treatment of breast cancer[J].Nanotechnology,2021,32(32): 325101. DOI:10.1088/1361-6528/abfc6f.
[37]	Jain P, Patel K, Jangid AK, et al. Biotinylated Mn₃O₄nanocuboids for targeted delivery of gemcitabine hydrochloride to breast cancer and MRI applications[J].Int J Pharm,2021,606: 120895. DOI:10.1016/j.ijpharm.2021.120895.

Progress of manganese-based nanomaterials in breast cancer diagnosis and treatment

RichHTML

PDF

Knowledge

Abstract

Cite this article

share this article

References37

Related Articles15

Recommended Articles

Metrics

Comments

[1]	Han Xiaoxu, Zhang Nan, Liu Shuai.Progress in the study of the pregnane X receptor in drug resistance in breast cancer[J]. Journal of International Oncology, 2024, 51(9): 590-594.
[2]	Zhao Biao, Pu Qin, Yuan Meifang, Ma Lishuang, Li Han, Yang Yi, Sun Chaoxi.Dosimetric study of intensity-modulated radiotherapy and volumetric intensity modulated arc therapy based on the inner edge tangent field for radiotherapy after breast-conserving surgery of left-sided breast cancer[J]. Journal of International Oncology, 2024, 51(7): 441-447.
[3]	Han Yi, Zhang Tongmei, Qi Fei, Zhang Yong.Advances in clinical molecular diagnosis and treatment of pulmonary large cell neuroendocrine carcinoma[J]. Journal of International Oncology, 2024, 51(7): 468-473.
[4]	Wang Ying, Liu Nan, Guo Bing.Advances of antibody-drug conjugate in the therapy of metastatic breast cancer[J]. Journal of International Oncology, 2024, 51(6): 364-369.
[5]	Sa Qiang, Xu Hangcheng, Wang Jiayu.Advances in immunotherapy for breast cancer[J]. Journal of International Oncology, 2024, 51(4): 227-234.
[6]	Yang Zhi, Lu Yiqiao, Gu Huayan, Ding Jialing, Guo Guilong.Research progress of tumor microenvironment mediated drug resistance in targeted therapy of breast cancer[J]. Journal of International Oncology, 2024, 51(4): 235-238.
[7]	Wang Zihao, Wang Yu, Yang Xin, He Yi, Mo Xingkui, Yuan Tao.Research progress on the molecular mechanism and related treatments of ferroptosis in osteosarcoma[J]. Journal of International Oncology, 2024, 51(4): 239-244.
[8]	Chen Boguang, Wang Sugui, Zhang Yongjie.Role of serum cholinesterase and inflammatory markers in the prognosis of stage ⅠA -ⅢA breast cancer[J]. Journal of International Oncology, 2024, 51(2): 73-82.
[9]	Gao Xinyu, Li Zhenjiang, Sun Hongfu, Han Dan, Zhao Qian, Liu Chengxin, Huang Wei.Clinical application of MR-guided radiotherapy based on MR-linac in esophageal cancer patients[J]. Journal of International Oncology, 2024, 51(1): 37-42.
[10]	Gu Huayan, Zhu Teng, Guo Guilong.Breast microbiota and breast cancer： present and future[J]. Journal of International Oncology, 2024, 51(1): 55-58.
[11]	Wang Jing, Xu Wenting.Value of NLR， CEA combined with coagulation indicators in the differential diagnosis of benign and malignant breast nodules with a diameter ≤ 1.0 cm[J]. Journal of International Oncology, 2023, 50(9): 520-526.
[12]	Feng Chengtian, Huang Furong, Cao Shiyu, Wang Jianyu, Nanding Abiyasi, Jiang Yongdong, Zhu Juanying.Relationships between HER2 protein expression and imaging features in HER2 positive breast cancer patients[J]. Journal of International Oncology, 2023, 50(9): 527-531.
[13]	Feng Dongxu, Wu Wei, Gao Pingfa, Wang Jun, Shi Lijuan, Chen Dawei, Li Wenbing, Zhang Meifeng.Effects of miR-451 on glycolysis and apoptosis of breast cancer cells by regulating Rho/ROCK1 pathway[J]. Journal of International Oncology, 2023, 50(8): 449-456.
[14]	Pan Shulan, Liu Chang, He Ping.Effect of fritinib on angiogenesis, tumor growth and IRE1-ASK1-JNK pathway in triple negative breast cancer[J]. Journal of International Oncology, 2023, 50(8): 457-462.
[15]	Wang Wende, Zeng De.Research progress on the mechanism of endocrine therapy resistance for breast cancer[J]. Journal of International Oncology, 2023, 50(6): 352-356.